The Cell & Gene Meeting on the Med is a premier European conference focusing on advanced therapy medicinal products (ATMPs). ATMPs are a revolutionary class of treatments that involve modifying a patient’s cells to fight disease. This conference unites researchers, developers, manufacturers, and other stakeholders from around the world who are working to advance this field.

The agenda dives deep into the challenges and opportunities surrounding bringing ATMPs to market. Key topics include navigating regulatory hurdles, securing funding, and developing efficient manufacturing processes. By fostering collaboration and knowledge exchange, the Cell & Gene Meeting on the Med aims to accelerate the development and accessibility of these potentially life-saving treatments.